Grifols
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Grifols and buy or sell other stocks, ETFs, and their options commission-free!About GRFS
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others.
CEONacho Abia
CEONacho Abia
Employees23,833
Employees23,833
HeadquartersBarcelona, Catalonia
HeadquartersBarcelona, Catalonia
Founded1940
Founded1940
Employees23,833
Employees23,833
GRFS Key Statistics
Market cap6.00B
Market cap6.00B
Price-Earnings ratio25.23
Price-Earnings ratio25.23
Dividend yield—
Dividend yield—
Average volume931.39K
Average volume931.39K
High today$7.86
High today$7.86
Low today$7.72
Low today$7.72
Open price$7.85
Open price$7.85
Volume867.09K
Volume867.09K
52 Week high$9.96
52 Week high$9.96
52 Week low$5.79
52 Week low$5.79
GRFS News
TipRanks 6d
Grifols SA Reports Strong Q1 2025 EarningsGrifols SA ((GRFS)) has held its Q1 earnings call. Read on for the main highlights of the call. Protect Your Portfolio Against Market Uncertainty Grifols SA’s...
TipRanks 6d
Grifols Exceeds Q1 2025 Forecasts with Strong Revenue and Profit GrowthProtect Your Portfolio Against Market Uncertainty An update from Grifols ( (ES:GRF) ) is now available. Grifols reported a strong financial performance in the...
TipRanks 6d
Grifols reports Q1 adjusted EBITDA of EUR 400M, up 14.2% from last yearNet revenues reached EUR 1.786B, up 7.4% in constant currency. Like-for-like net revenues increased by 10.0% in constant currency. Adjusted EBITDA increased to...
More GRFS News
TipRanks 7d
Grifols reaffirms guidance for 2025Grifols (GRFS) said: “Grifols remains focused on the continued execution of its strategic plan and reaffirms its guidance for FY2025. Due to the impact of the I...